anmelden
OMX Nordic 40
2.707,24
PKT
-25,85
PKT
-0,95
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.08.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 29.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.08.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 21.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 21.08.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 18.08.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 15.08.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 15.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 15.08.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 14.08.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 11.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 11.08.23 | Novo Nordisk Sell | UBS AG | |
| 11.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 10.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.08.23 | Volvo (B) Sell | UBS AG | |
| 09.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.08.23 | Novo Nordisk Sell | UBS AG | |
| 08.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 08.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 08.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.08.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
| 07.08.23 | A.P. Moeller - Maersk A-S (B) Sell | Goldman Sachs Group Inc. | |
| 07.08.23 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 03.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.07.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 28.07.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.07.23 | ABB (Asea Brown Boveri) Neutral | Credit Suisse Group | |
| 25.07.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.07.23 | Nokia Buy | Deutsche Bank AG | |
| 24.07.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 24.07.23 | Ericsson (Telefon L.M.Ericsson) (B) Overweight | JP Morgan Chase & Co. | |
| 24.07.23 | Nokia Overweight | JP Morgan Chase & Co. | |
| 24.07.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. |
